Citadel Advisors’s Hyperfine HYPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.7K Sell
14,500
-15,600
-52% -$17.7K ﹤0.01% 12707
2025
Q4
$29.5K Buy
30,100
+3,700
+14% +$4.46K ﹤0.01% 12229
2025
Q3
$38.3K Buy
+26,400
New +$30.8K ﹤0.01% 12311
2025
Q2
Sell
-16,700
Closed -$12K 13641
2025
Q1
$12K Buy
16,700
+14,600
+695% +$15K ﹤0.01% 13465
2024
Q4
$1.85K Buy
2,100
+1,000
+91% +$962 ﹤0.01% 14142
2024
Q3
$1.19K Buy
1,100
+200
+22% +$213 ﹤0.01% 13884
2024
Q2
$765 Sell
900
-1,800
-67% -$1.58K ﹤0.01% 13920
2024
Q1
$2.7K Buy
+2,700
New +$2.9K ﹤0.01% 13978
2022
Q4
Sell
-14,400
Closed -$12K 15112
2022
Q3
$12K Buy
+14,400
New +$20.3K ﹤0.01% 12225

Other funds holding HYPR

Citadel Advisors's HYPR Position: Q1 2026 in Review

Citadel Advisors sold out of Hyperfine (HYPR) in Q1 2026, closing a stake of 10,992 shares — an estimated $12.5K sold.

Citadel Advisors first reported a position in HYPR in Q3 2022 and held it in 7 quarters. The position peaked at $163K in Q4 2023. 50 funds tracked by Wall St. Rank hold HYPR as of Q1 2026.

  • Citadel Advisors reported no remaining Hyperfine position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 10,992 Hyperfine shares in Q1 2026, an estimated $12.5K.
  • Citadel Advisors first reported a position in Hyperfine in Q3 2022 and held it in 7 quarters.
  • Citadel Advisors's Hyperfine position peaked at $163K in Q4 2023.
  • 50 funds tracked by Wall St. Rank held Hyperfine as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.